# Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial - Star AF II Study

> **NCT01203748** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 589 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **PROCEDURE:** PVI + Lines ablation
- **PROCEDURE:** PVI
- **PROCEDURE:** PVI + CFE ablation

## Key facts

- **NCT ID:** NCT01203748
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 589 (ACTUAL)
- **Last updated:** 2019-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01203748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01203748, "Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial - Star AF II Study". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01203748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*